A. Safdar

1.0k total citations
16 papers, 704 citations indexed

About

A. Safdar is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, A. Safdar has authored 16 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in A. Safdar's work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (5 papers) and Neutropenia and Cancer Infections (4 papers). A. Safdar is often cited by papers focused on Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (5 papers) and Neutropenia and Cancer Infections (4 papers). A. Safdar collaborates with scholars based in United States, India and Puerto Rico. A. Safdar's co-authors include K. V. I. Rolston, Donald Armstrong, Issam Raad, Dimitrios P. Kontoyiannis, Russell E. Lewis, Gregory A. Lamaris, Georgios Chamilos, D. P. Kontoyiannis, Esperanza B. Papadopoulos and James W. Young and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

A. Safdar

14 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Safdar United States 11 343 342 182 136 85 16 704
Hideki Araoka Japan 17 240 0.7× 226 0.7× 189 1.0× 106 0.8× 101 1.2× 62 819
Hannah Sprecher Israel 17 354 1.0× 253 0.7× 49 0.3× 86 0.6× 144 1.7× 31 932
Jae-Ki Choi South Korea 16 292 0.9× 250 0.7× 80 0.4× 94 0.7× 59 0.7× 35 558
R. Pericás Spain 14 241 0.7× 137 0.4× 91 0.5× 60 0.4× 62 0.7× 22 572
Muneyoshi Kimura Japan 15 126 0.4× 156 0.5× 107 0.6× 66 0.5× 56 0.7× 40 460
Takashi Shinzato Japan 15 225 0.7× 168 0.5× 104 0.6× 30 0.2× 121 1.4× 47 690
Paul McWhinney United Kingdom 15 439 1.3× 337 1.0× 60 0.3× 117 0.9× 47 0.6× 27 748
Richard E. Winn United States 16 382 1.1× 388 1.1× 47 0.3× 57 0.4× 69 0.8× 51 875
C. A. S. Martins Brazil 11 465 1.4× 513 1.5× 47 0.3× 161 1.2× 35 0.4× 12 741
Yingnan Huang China 8 503 1.5× 218 0.6× 41 0.2× 28 0.2× 142 1.7× 10 744

Countries citing papers authored by A. Safdar

Since Specialization
Citations

This map shows the geographic impact of A. Safdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Safdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Safdar more than expected).

Fields of papers citing papers by A. Safdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Safdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Safdar. The network helps show where A. Safdar may publish in the future.

Co-authorship network of co-authors of A. Safdar

This figure shows the co-authorship network connecting the top 25 collaborators of A. Safdar. A scholar is included among the top collaborators of A. Safdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Safdar. A. Safdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sharma, Pradakshina, et al.. (2026). Advances in the synthesis, properties, and applications of iron oxide nanoparticles. SHILAP Revista de lepidopterología. 2(1).
3.
Safdar, A. & Donald Armstrong. (2011). Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic Defects. Clinical Infectious Diseases. 53(8). 798–806. 92 indexed citations
4.
Lamaris, Gregory A., Bita Esmaeli, Georgios Chamilos, et al.. (2008). Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. European Journal of Clinical Microbiology & Infectious Diseases. 27(5). 343–347. 39 indexed citations
5.
Safdar, A., Gabriel Rodriguez, K. V. I. Rolston, et al.. (2007). High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplantation. 39(3). 157–164. 36 indexed citations
6.
Aisenberg, Gabriel M., K. V. I. Rolston, Burton F. Dickey, et al.. (2007). Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997–2004. European Journal of Clinical Microbiology & Infectious Diseases. 26(1). 13–20. 61 indexed citations
7.
Safdar, A. & K. V. I. Rolston. (2007). Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer. Clinical Infectious Diseases. 45(12). 1602–1609. 158 indexed citations
8.
Safdar, A., et al.. (2007). Polymicrobial bloodstream infections (PBI): An under-realized complication in patients with cancer (2005–2006). Journal of Clinical Oncology. 25(18_suppl). 19590–19590. 1 indexed citations
9.
Safdar, A., Gabriel Rodriguez, Maya Balakrishnan, Jeffrey J. Tarrand, & K. V. I. Rolston. (2006). Changing trends in etiology of bacteremia in patients with cancer. European Journal of Clinical Microbiology & Infectious Diseases. 25(8). 522–526. 24 indexed citations
10.
Lamaris, Gregory A., Georgios Chamilos, Russell E. Lewis, et al.. (2006). Scedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006. Clinical Infectious Diseases. 43(12). 1580–1584. 119 indexed citations
11.
Safdar, A.. (2006). Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections. Bone Marrow Transplantation. 38(5). 327–337. 32 indexed citations
12.
Torres, Harrys A., Roy F. Chemaly, Elizabeth Aguilera, et al.. (2006). Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. European Journal of Clinical Microbiology & Infectious Diseases. 25(6). 382–388. 59 indexed citations
13.
Safdar, A., Gabriela Rodrı́guez, K. V. I. Rolston, et al.. (2006). 94 Efficacy of high-dose (100mg daily) Caspofungin (HD-CASP) combination antifungal therapy in cancer patients with invasive fungal infections (IFIs): Case-controlled observational analysis during 2002–2004. International Journal of Infectious Diseases. 10. S53–S53. 1 indexed citations
14.
Jacobson, Kerry L., et al.. (2004). Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990–2000. Clinical Microbiology and Infection. 10(8). 749–752. 41 indexed citations
15.
Safdar, A., et al.. (2002). Clinical microbiological case: severe relapsing septal panniculitis in a healthy man from the south-eastern USA. Clinical Microbiology and Infection. 8(12). 801–802. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026